Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / MED BREAKTHGH
-
Total 13F shares
-
1,478,637
-
Share change
-
-34,690
-
Total reported value
-
$60,818,238
-
Put/Call ratio
-
0%
-
Price per share
-
$41.13
-
Number of holders
-
51
-
Value change
-
-$1,490,077
-
Number of buys
-
24
-
Number of sells
-
23
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q3 2020
As of 30 Sep 2020,
ALPS ETF TR - MED BREAKTHGH (SBIO) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,478,637 shares.
The largest 10 holders included
MORGAN STANLEY, UBS Group AG, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, NTV Asset Management LLC, Tower Research Capital LLC (TRC), Cardan Capital Partners, LLC, COMMONWEALTH EQUITY SERVICES, LLC, and ADVISOR GROUP HOLDINGS, INC..
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.